Send us a text Andy and JC get the lowdown from Robert Pacifici, CSO of CHDI Foundation, on the latest in Huntington's treatments from the recent 20th CHDI Therapeutics Conference in Palm Springs, California. Robert has spearheaded efforts at CHDI for the past 22 years, driving forward preclinical drug discovery programs and corralling efforts to develop bioassays, clinical biomarkers, patient-staging systems, clinical and regulatory consortia to galvanize industry efforts in this devastating...
All content for The Translational Mixer is the property of Andy Marshall and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text Andy and JC get the lowdown from Robert Pacifici, CSO of CHDI Foundation, on the latest in Huntington's treatments from the recent 20th CHDI Therapeutics Conference in Palm Springs, California. Robert has spearheaded efforts at CHDI for the past 22 years, driving forward preclinical drug discovery programs and corralling efforts to develop bioassays, clinical biomarkers, patient-staging systems, clinical and regulatory consortia to galvanize industry efforts in this devastating...
Episode 2: Eric Topol, multimodal AI models in medicine, and a glass of Merlot
The Translational Mixer
41 minutes
1 year ago
Episode 2: Eric Topol, multimodal AI models in medicine, and a glass of Merlot
Send us a text Scripps' Eric Topol is a visionary in the application of artificial intelligence to medicine. He has a wide-ranging conversation with JC and Andy about : 02:52 Multimodal AI is coming 06:44 FDA-approved AI software 10:02 How to validate AI models? 12:50 Synthetic doctor’s notes and other early applications 15:38 Thinking about the model and its training 19:28 Dealing with hallucination and GPT5 24:13 Low-to-middle income countries 27:40 Uptake by the medical c...
The Translational Mixer
Send us a text Andy and JC get the lowdown from Robert Pacifici, CSO of CHDI Foundation, on the latest in Huntington's treatments from the recent 20th CHDI Therapeutics Conference in Palm Springs, California. Robert has spearheaded efforts at CHDI for the past 22 years, driving forward preclinical drug discovery programs and corralling efforts to develop bioassays, clinical biomarkers, patient-staging systems, clinical and regulatory consortia to galvanize industry efforts in this devastating...
